Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-312025-03-31The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.falseNo description of principal activitytrue2024-04-01false22false 07212228 c:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 07212228 d:ComputerSoftware 2025-03-31 07212228 d:ComputerSoftware 2024-03-31 07212228 d:CurrentFinancialInstruments 2025-03-31 07212228 d:CurrentFinancialInstruments 2024-03-31 07212228 c:Director1 2024-04-01 2025-03-31 07212228 c:FRS102 2024-04-01 2025-03-31 07212228 c:FullAccounts 2024-04-01 2025-03-31 07212228 c:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 07212228 d:RetainedEarningsAccumulatedLosses 2025-03-31 07212228 d:RetainedEarningsAccumulatedLosses 2024-03-31 07212228 d:ShareCapital 2025-03-31 07212228 d:ShareCapital 2024-03-31 07212228 2024-04-01 2025-03-31 07212228 2025-03-31 07212228 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-31 07212228 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 07212228 2023-04-01 2024-03-31 07212228 2024-03-31 07212228 2 2024-04-01 2025-03-31 07212228 e:PoundSterling 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure
Registered number: 07212228


NEURODESIGN LIMITED
UNAUDITED
FINANCIAL STATEMENTS
INFORMATION FOR FILING WITH THE REGISTRAR
FOR THE YEAR ENDED 31 MARCH 2025

 
NEURODESIGN LIMITED
 

CONTENTS



Page
Balance sheet
 
 
Notes to the financial statements
 
 
2 - 5


BALANCE SHEET
AS AT 31 MARCH 2025

2025
2024
Note
£
£

  

Current assets
  

Cash at bank and in hand
 5 
87,961
81,721

Creditors: amounts falling due within one year
 6 
(26,820)
(24,752)

Net current assets
  
 
 
61,141
 
 
56,969

  

Net assets
  
61,141
56,969


Capital and reserves
  

Called up share capital 
  
1
1

Profit and loss account
  
61,140
56,968

  
61,141
56,969


The Directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The Directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by:

 
NEURODESIGN LIMITED
REGISTERED NUMBER:07212228
    
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2025





................................................
R D Ashpole
Director

Date: 10 December 2025

The notes on pages 2 to 5 form part of these financial statements.

Page 1

 
NEURODESIGN LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1.


General information

Neurodesign Limited is a company limited by shares, registered in England, registered number 07212228. The registered office is Brook House, Main Street, Willoughby-on-the-Wolds, Loughborough, LE12 6SY and is the principal place of business.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Going concern

The Directors have looked forward 12 months and have concluded that the Company should be able
to operate within its current cash resources for the foreseeable future and therefore believe it is
appropriate to prepare these financial statements on a going concern basis.

 
2.3

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Page 2

 
NEURODESIGN LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.4

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.5

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.6

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


  
2.7

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.
All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.
Amortisation is provided on the following basis:
       Website - 20% Straight line

 
2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Page 3

 
NEURODESIGN LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.9

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.10

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2024 - 2).


4.


Intangible assets




Website

£



Cost


At 1 April 2024
1,800



At 31 March 2025

1,800



Amortisation


At 1 April 2024
1,800



At 31 March 2025

1,800



Net book value



At 31 March 2025
-



At 31 March 2024
-



Page 4

 
NEURODESIGN LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

5.


Cash and cash equivalents

2025
2024
£
£

Cash at bank and in hand
87,961
81,721



6.


Creditors: Amounts falling due within one year

2025
2024
£
£

Corporation tax
1,096
606

Other creditors
23,684
22,130

Accruals and deferred income
2,040
2,016

26,820
24,752



7.


Financial instruments

All debtors and creditors are basic financial instruments and held at amortised cost.


8.


Related party transactions

At 31 March 2025 there was a balance owing by the company to Mr R D Ashpole of £23,684 (2024 - £22,130). This amount is included within other creditors in note 6 of these financial statements.

 
Page 5